Ipratropium Bromide And Albuterol Sulfate
Product Images NDC 50090-6288

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 50090-6288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing lung volume in liters over time (hours after dosing) for three treatments: Albuterol, Ipratropium, and the combination Ipratropium bromide and Albuterol sulfate inhalation solution. The graph compares their effects from 0 to 8 hours post-dose, with each treatment represented by distinct markers and a dashed line connecting the points.*

FDA Label Image

Figure2 (Figure2)

An instructional illustration showing two hands assembling components of a medical inhaler device. One hand holds a mouthpiece and the other positions a cartridge or canister into the inhaler base. The diagram appears to guide proper insertion or assembly of the inhaler parts.*

FDA Label Image

Figure3 (Figure3)

An instructional illustration showing hands assembling or connecting parts of a nebulizer mouthpiece or inhaler device, specifically attaching a mouthpiece component. The image is a black-and-white line drawing with step number 2 indicated.*

FDA Label Image

Figure4 (Figure4)

Instructional illustration showing two steps for using an inhaler device. The first step depicts a person placing the mouthpiece of the inhaler into their mouth. The second step shows the person exhaling into a spacer or holding chamber attached to the inhaler.*

FDA Label Image

Label Image (Lbl500906288)

Label from A-S Medication Solutions for Ipratropium Bromide and Albuterol Sulfate, product number 6445-0, NDC 50090-6288-0. The label notes a unit dose vial packaging with each vial containing 3 mL. It specifies strengths of Ipratropium Bromide USP 0.05 mg and Albuterol Sulfate USP equivalent to 2.5 mg Albuterol base. Storage recommendations include refrigeration at 8 to 17 degrees Celsius and protection from light. Package includes 30 unit dose vials in 6 pouches, each containing 5 mL vials. Additional lot and expiration information is present.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of Albuterol Sulfate showing the molecular arrangement including hydroxyl groups and sulfate ions, consistent with the active ingredient in Ipratropium Bromide and Albuterol Sulfate.*

FDA Label Image

Structure2 (Structure2)

Chemical structure diagram of ipratropium bromide showing the arrangement of atoms, including a quaternary ammonium group and bromide hydrate (Br•H2O). This structural formula represents the active ingredient ipratropium bromide in the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.